Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
225 participants
OBSERVATIONAL
2009-02-28
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to evaluate the safety and efficacy of the HINTEGRA® Total Ankle prosthesis at short and mid term follow up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement
NCT03247023
Osseointegrated Transtibial Prosthesis With Neural Interface
NCT05249049
INBONE™ Total Ankle Prosthesis With Long Talar Stem
NCT01641848
Post- Approval Hintermann Series H® Study 1
NCT06514196
Zimmer Trabecular Metal Total Ankle PMCF
NCT02038140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HINTEGRA
Patient Implanted with the HINTEGRA Total Ankle Prosthesis more than 2 years ago
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Have willingness to give his/her data transfer authorisation
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Integra LifeSciences Services
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Innsbruck
Innsbruck, , Austria
St. Michael's Hospital
Toronto, , Canada
CHU d'Amiens - Hopital Nord
Amiens, , France
AukammKlinik
Wiesbaden, , Germany
Severance Hospital - Yonsei University
Seoul, , South Korea
Hopital San Rafael
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECON-EMEA-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.